In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

Member Benefit

This content is only available year-round to EHRA Ivory (& above) Members, Fellows of the ESC and Young combined Members

Genetic basis for tailored drug therapy for ventricular arrhythmias

Session Critical appraisal of antiarrhythmic drug therapy - The science behind trial-and-error

Speaker Associate Professor Carol Ann Remme

Event : EHRA 2019

  • Topic : basic science
  • Sub-topic : Arrhythmias
  • Session type : New ESC Guidelines

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are